Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 12, 2018 13:35 ET | Source: Kalytera Therapeutics, Inc.

Kalytera Announces Next Share Issuance for Services under Payments Agreement with Salzman Group

SAN FRANCISCO and TEL AVIV, Israel, Nov. 12, 2018 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE: KALY and OTCQB: KALTF) (the "Company" or "Kalytera") today announced that the Company...
September 28, 2018 07:30 ET | Source: Kalytera Therapeutics, Inc.

Kalytera Announces Next Share Issuance under Payments Agreements with Salzman Group

SAN FRANCISCO and TEL AVIV, Israel, Sept. 28, 2018 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE: KALY and OTCQB: KALTF) (the "Company" or "Kalytera") today announced that the Company...
September 24, 2018 20:07 ET | Source: Kalytera Therapeutics, Inc.

Kalytera Announces Grant of Stock Options to Directors and Employees

SAN FRANCISCO and TEL AVIV, Israel, Sept. 24, 2018 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE: KALY and OTCQB: KALTF) (the "Company" or "Kalytera") today announced that it has...
September 13, 2018 15:11 ET | Source: Kalytera Therapeutics, Inc.

Kalytera Confirms No Material Change in Operations

SAN FRANCISCO and TEL AVIV, Israel, Sept. 13, 2018 (GLOBE NEWSWIRE) -- At the request of IIROC, Kalytera Therapeutics, Inc. (TSX VENTURE: KALY and OTCQB: KALTF) (the "Company" or "Kalytera") wishes...
September 07, 2018 17:34 ET | Source: Kalytera Therapeutics, Inc.

Kalytera Announces Next Payment of Invoices in Shares under Payments Agreements with Salzman Group

SAN FRANCISCO and TEL AVIV, Israel, Sept. 07, 2018 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE: KALY and OTCQB: KALTF) (the "Company" or "Kalytera") today announced that the Company...
August 24, 2018 08:27 ET | Source: Kalytera Therapeutics, Inc.

Kalytera Provides Update on Arrangement with Former Shareholders of Talent Biotechs

SAN FRANCISCO and TEL AVIV, Israel, Aug. 24, 2018 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE: KALY and OTCQB: KALTF) (the "Company" or "Kalytera") today provided an update on the...
August 17, 2018 17:09 ET | Source: Kalytera Therapeutics, Inc.

Kalytera Announces Further Payments in Shares under Payments Agreements with Salzman Group

SAN FRANCISCO and TEL AVIV, Israel, Aug. 17, 2018 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (TSX VENTURE: KALY and OTCQB: KALTF) (the "Company" or "Kalytera") today announced that the Company...
August 16, 2018 11:05 ET | Source: Kalytera Therapeutics, Inc.

Kalytera Therapeutics, Inc. Announces Exercise of Over-Allotment Option

Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws. SAN FRANSISCO...
August 08, 2018 12:59 ET | Source: Kalytera Therapeutics, Inc.

Kalytera Therapeutics, Inc. Announces Closing of Public Offering

Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws. SAN FRANSISCO...
July 27, 2018 17:08 ET | Source: Kalytera Therapeutics, Inc.

Kalytera Therapeutics Announces Adjournment of 2018 Annual and Special Meeting

SAN FRANCISCO and TEL AVIV, Israel, July 27, 2018 (GLOBE NEWSWIRE) -- Kalytera Therapeutics, Inc. (the “Company”, or “Kalytera”) (TSXV:KALY) (OTCQB:KALTF) announced today that the annual and special...